Lisa Porter, University of Windsor

Research

Cell Cycle Zebrafish Models Cdk Inhibitors Mouse Models Drug Resistance Drug Testing Polyploidy Regeneration

Latest papers

Clinical Significance of Tumor Grade in Triple-Negative Breast Cancer: A Retrospective Cohort Analysis.
Biomedicines · 2025
An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomic, Interactomic, and Transcriptomic Data.
Journal of computational biology : a journal of computational molecular cell biology · 2017
Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme.
Drugs in R&D · 2017 · senior author

All 3 publications

Latest funding

Elucidating the Mechanism Behind Chemotherapy-Induced Senescence Exit as a Precursor to Relapse in Triple Negative Breast Cancer (TNBC) Patients
CIHR · 2023 · Supervisor
$105,000
Role of Cyclin-Like Proteins in Regulating the Regenerative Balance in the Liver; Implications in Fatty Liver Disease and Hepatocellular Carcinoma
CIHR · 2022 · Nominated PI
$745,875
Role of Tuberin in Cell Size and Mitotic Progression
NSERC · 2022 · Principal investigator
$144,000

All 27 grants and awards

3 publications.

01

Clinical Significance of Tumor Grade in Triple-Negative Breast Cancer: A Retrospective Cohort Analysis.

Ramanan N, Malik MN, Upneja S, Farooq H, Kulkarni S, Gupta R, Mathews J, Nasser A, Bocicariu A, Arayan L, Porter L, Fifield BA, Luo R, Brackstone M, Hamm C

Biomedicines2025

DOI: 10.3390/biomedicines13051100 PMID: 40426927

02

An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomic, Interactomic, and Transcriptomic Data.

Firoozbakht F, Rezaeian I, D'agnillo M, Porter L, Rueda L, Ngom A

Journal of computational biology : a journal of computational molecular cell biology2017

DOI: 10.1089/cmb.2017.0010 PMID: 28650678

03

Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme.

Lubanska D, Porter L

Drugs in R&D2017Senior author

DOI: 10.1007/s40268-017-0180-1 PMID: 28324583

Elucidating the Mechanism Behind Chemotherapy-Induced Senescence Exit as a Precursor to Relapse in Triple Negative Breast Cancer (TNBC) Patients

SupervisorCIHR2023Doctoral Research Award: Canada Graduate Scholarships

Principal investigators: Philbin, Nick J

Keywords: Aldh1; Anti/Pro-Tumour Immune Cells; Breast Cancer (Bc); Breast Cancer Stem Cells (Bcscs); Cell Cycle; Disease Recurrence; Senescence; Spy1; Triple Negative Breast Cancer (Tnbc); Zebrafish

$105,000

Role of Cyclin-Like Proteins in Regulating the Regenerative Balance in the Liver; Implications in Fatty Liver Disease and Hepatocellular Carcinoma

Nominated PICIHR2022Project Grant

Principal investigators: Porter, Lisa A

Keywords: Animal Models; Cancer; Cell Cycle; Drug Resistance; Drug Testing; Hepatocyte Biology; Liver Disease; Polyploidy; Regeneration; Zebrafish Models

$745,875

Role of Tuberin in Cell Size and Mitotic Progression

Principal investigatorNSERC2022Discovery Grants Program - Individual

Principal investigators: Porter, Lisa

$144,000

Multi-User High Throughput Flow Cytometry System

Co-investigatorNSERC2022Research Tools and Instruments

Principal investigators: Rahim, Mir Munir

$147,065

Catalyzing Community Connection - Population Health Cross-Border Project

Co-investigatorCIHR2022Planning and Dissemination Grant - Institute Community Support

Principal investigators: Pfaff, Kathryn A

Keywords: Capacity Building; Compassionate Communities; Health Equity; Health Promotion; Implementation Science; Knowledge Mobilization; Population Health

$19,981

Evidence-based decision-making to counter the effects of emerging pathogens on cross-border economic activity

Co-investigatorSSHRC2022New Frontiers in Research Fund - Special Calls

Principal investigators: Ng, Kenneth

Keywords: Psychosocial determinants of health; Health promotion; Public health; Cross-border trade; Environmental microbiology; Infectious disease; Emerging pathogens

$250,000

Optimizing a Cost-efficient and Scalable COVID-19 Early Warning System at a Strategic Canadian Land Entry Point

Co-investigatorCIHR2021Op Gr: Emerging COVID-19 Research Gap & Priorities - Testing models/surveillance

Principal investigators: Tong, Yufeng

Keywords: Molecular Diagnosis; Wastewater Surveillance

$500,000

Multi-user in vivo animal imaging system

Co-investigatorNSERC2020Research Tools and Instruments

Principal investigators: Rahim, MirMunir

$150,000

Understanding mechanism of action: Combined computational and structural biology studies to determine small molecule effects on protein dynamics and function_x000d_ _x000d_

Co-investigatorNSERC2020Alliance Grants

Principal investigators: Trant, John

$450,869

Evaluating the persistence of SARS-CoV-2 (COVID-19) in the urban water cycle_x000d_ _x000d_

Co-investigatorNSERC2020Alliance Grants

Principal investigators: McKay, Robert

$50,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Biomedical Sciences
Other

Co-authors at University of Windsor, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Caroline Hamm

Faculty

1 shared papers, latest 2025

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2022

Subject: Prospective PhD student: Cell Cycle Dear Professor Porter, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Clinical Significance of Tumor Grade in Triple-Negative Breast Cancer: A Retrospective Cohort Analysis." (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Role of Cyclin-Like Proteins in Regulating the Regenerative Balance in the Liver; Implications in Fatty Liver Disease and Hepatocellular Carcinoma" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Lisa Porter